Arena Pharmaceuticals Inc.
|
 | ||||||||||
|
 |
  |
 |
|
|
||
 |
 |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
 
 |
return to message board, top of board |
Q mid-dose vs. Lorc/shari "...Epilepsy dose is 400mg, typically for 120 lbs skinny epileptic women, mid dose Qnexa topiramate is 48mg for typically 220 lbs obese women...."
----
sooo, just like the Vivus CEO at the Q AdCom, you're also now touting the Q mid-dose? LOL
if so, then surely you realize that mid-dose Q has about the same efficacy as Lorc, thus negating the often mentioned efficacy advantage that Q has over Lorc
|
|||||||||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 22640 | Re: Q mid-dose vs. Lorc/shari / binary | sharikook | 1 | 5/30/2012 3:20:25 PM |
